- Home
- ENTA vs NEWP Comparison
ENTA vs NEWP Comparison
Compare ENTA & NEWP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENTA
- NEWP
- Stock Information
- Founded
- ENTA 1995
- NEWP 1972
- Country
- ENTA United States
- NEWP Canada
- Employees
- ENTA N/A
- NEWP N/A
- Industry
- ENTA Biotechnology: Pharmaceutical Preparations
- NEWP
- Sector
- ENTA Health Care
- NEWP
- Exchange
- ENTA Nasdaq
- NEWP Nasdaq
- Market Cap
- ENTA 245.4M
- NEWP 264.1M
- IPO Year
- ENTA 2013
- NEWP N/A
- Fundamental
- Price
- ENTA $9.31
- NEWP $1.53
- Analyst Decision
- ENTA Buy
- NEWP Strong Buy
- Analyst Count
- ENTA 3
- NEWP 1
- Target Price
- ENTA $19.67
- NEWP $5.00
- AVG Volume (30 Days)
- ENTA 114.1K
- NEWP 291.4K
- Earning Date
- ENTA 11-25-2024
- NEWP 11-13-2024
- Dividend Yield
- ENTA N/A
- NEWP N/A
- EPS Growth
- ENTA N/A
- NEWP N/A
- EPS
- ENTA N/A
- NEWP N/A
- Revenue
- ENTA $71,960,000.00
- NEWP N/A
- Revenue This Year
- ENTA N/A
- NEWP N/A
- Revenue Next Year
- ENTA $5.14
- NEWP N/A
- P/E Ratio
- ENTA N/A
- NEWP N/A
- Revenue Growth
- ENTA N/A
- NEWP N/A
- 52 Week Low
- ENTA $8.51
- NEWP $0.87
- 52 Week High
- ENTA $17.80
- NEWP $2.53
- Technical
- Relative Strength Index (RSI)
- ENTA 28.86
- NEWP 43.69
- Support Level
- ENTA $10.84
- NEWP $1.45
- Resistance Level
- ENTA $10.89
- NEWP $1.62
- Average True Range (ATR)
- ENTA 0.49
- NEWP 0.10
- MACD
- ENTA -0.19
- NEWP -0.02
- Stochastic Oscillator
- ENTA 18.18
- NEWP 24.24
About ENTA Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc is an American biotechnology company focused on the research and development of molecule drugs to cure viral infections and liver diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.
About NEWP New Pacific Metals Corp.
New Pacific Metals Corp is a Canadian Mining Issuer, in the business of exploring and developing precious metal properties in Bolivia. The company's projects which are also its reportable segments include Silver Sand; Carangas and Silverstrike.